MR编号 | CZ/H/0920/001 |
---|
药品名称 | Clindamycin hameln |
---|
活性成分 | - Clindamycin phosphate 150.0 mg/ml
|
---|
剂型 | Solution for injection/infusion |
---|
上市许可持有人 | Hameln pharma gmbh,
Inselstraße 1, 31787 Hameln,
Germany |
---|
参考成员国 - 产品名称 | Czechia (CZ) Clindamycin hameln |
---|
互认成员国 - 产品名称 | - Slovenia (SI)
- Croatia (HR)
Klindamicin hameln 150 mg/ml otopina za injekciju / infuziju - Germany (DE)
Clindamycin hameln 150 mg/ml Injektions- /Infusionslösung - United Kingdom (Northern Ireland) (XI)
- Netherlands (NL)
- Austria (AT)
- Denmark (DK)
- Sweden (SE)
- Poland (PL)
Clindamycin S.MED - Hungary (HU)
- Bulgaria (BG)
Clindamycin S,MED - Romania (RO)
- Slovakia (SK)
Clindamycin hameln 150 mg/ml injekčný/infúzny roztok
|
---|
许可日期 | 2021/03/18 |
---|
最近更新日期 | 2024/11/26 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|